REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,310,448 | -62.6% | 114,250 | -17.6% | 0.00% | -76.9% |
Q2 2023 | $3,507,890 | +105.4% | 138,597 | +161.4% | 0.01% | +85.7% |
Q1 2023 | $1,707,806 | -34.8% | 53,021 | -62.6% | 0.01% | -50.0% |
Q4 2022 | $2,619,105 | +238.4% | 141,880 | +394.9% | 0.01% | +180.0% |
Q3 2022 | $774,000 | +11.4% | 28,669 | +22.3% | 0.01% | -37.5% |
Q2 2021 | $695,000 | +92.5% | 23,435 | +63.3% | 0.01% | +60.0% |
Q3 2020 | $361,000 | +12.8% | 14,353 | +9.4% | 0.01% | 0.0% |
Q2 2020 | $320,000 | – | 13,117 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |